Explore Fosun Pharma

  • Hot News

    100 Million Vials for Severe Malaria Treatments Supplied by Fosun Pharma, Estimated to Have Saved Over 20 Million Lives Worldwide

    Shanghai, China-November 5th, 2017-- Guilin Pharma, a member of Fosun Pharma (stock codes: 600196. SH; 02196, HK), ...

    Details
  • Hot News

    Strengthening Innovation Capacity Propelling Internationalization Progress Fosun Pharma Revenue Increased 20.41% while R&D Expenses and Overseas Revenue Grew by More than 50%

    30 August 2017, Chinese leading healthcare group Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma”, sto...

    Details
  • Hot News

    2016 Fosun Pharma Net Profit (after extraordinary gain or loss) Attributable to Shareholders Increased 26.36% Continued Efforts in Innovative R&D Strengthening the Strategic Layout of Healthcare Services

    [30 March 2017 Hong Kong] On March 28, 2017, China’s leading healthcare Group Shanghai Fosun Pharmaceutical (Group) ...

    Details
  • Hot News

    Another “Milestone” of Sino-Sweden Business Cooperation Fosun Pharma Acquired Breas – a Leading European Ventilator Brand

    (22 March, 2017 Shanghai) Fosun Pharma recently conducted the signing ceremony for its majority investment in Breas ...

    Details

Quality System

13
GMP Certification

Innovation

Fosun Pharma Shares (A+H)

SH 600196

24.79

+0.52 +2.80%

2015-04-15 14:48:05

HK 02196

25.85

+0.52 +12.10%

2015-04-15 14:48:05

Refer to the Annual Financial Report

Recruitment

0
Recruitment Posts

Join Fosun Pharma